Pyramid Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Pyramid Biosciences's estimated annual revenue is currently $1.2M per year.
- Pyramid Biosciences's estimated revenue per employee is $77,500
Employee Data
- Pyramid Biosciences has 15 Employees.
- Pyramid Biosciences grew their employee count by -17% last year.
Pyramid Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Board Directors, Co-Founder | Reveal Email/Phone |
3 | VP, Nonclinical Safety | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Financial and Strategy Officer | Reveal Email/Phone |
6 | Clinical Trial Manager | Reveal Email/Phone |
7 | Sr. Clinical Trial Assistant | Reveal Email/Phone |
8 | Clinical Operations Consultant | Reveal Email/Phone |
Pyramid Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Pyramid Biosciences?
Pyramid Biosciences is dedicated to discovering and developing targeted therapeutics for a wide range of disorders that are regulated by the tropomyosin receptor kinase (TRK) family. By precisely and selectively modulating the actions of these fundamental cell surface receptors, we can control the key signaling pathways responsible for a patient’s disease, condition or symptoms.
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.2M | 15 | -77% | $263.3M |
#2 | $0.9M | 15 | -37% | N/A |
#3 | $1.2M | 15 | N/A | N/A |
#4 | $1.4M | 15 | N/A | N/A |
#5 | $2M | 15 | N/A | N/A |
